Operator
Greetings, and welcome to the TransAct Applied sciences Third Quarter 2025 Earnings Name. [Operator Instructions] And as a reminder, this convention is being recorded. It’s now my pleasure to introduce Ryan Gardella of Investor Relations. Please go forward.
Ryan Gardella
Thanks. Good afternoon, and welcome to the TransAct Applied sciences Third Quarter 2025 Earnings Name. In the present day, we’ll be discussing the outcomes introduced in our press launch issued after market shut. Current from the corporate is CEO, John Dillon and President and CFO, Steve DeMartino. In the present day’s name will embrace a dialogue of the corporate’s key working methods, the progress on these initiatives and particulars on the third quarter monetary outcomes.
We’ll then open the decision to individuals for questions. As a reminder, this convention name accommodates statements about future occasions and expectations, that are forward-looking in nature. Statements on this name could also be deemed as forward-looking and precise outcomes could differ materially. For a full record of dangers inherent to the enterprise and the corporate, please consult with the corporate’s SEC filings, together with its experiences on Type 10-Q and 10-Okay. TransAct undertakes no obligation to revise or replace any forward-looking statements to mirror occasions or circumstances that happen after the decision.
In the present day’s name and webcast will embrace non-GAAP monetary measures inside the which means of SEC Regulation G. When required, a reconciliation of all non-GAAP monetary measures to probably the most straight comparable monetary measures calculated and offered in accordance with GAAP might be present in immediately’s press launch in addition to on the corporate web site. And with that, I might